Relationship of Established Cardiovascular Risk Factors and Peripheral Biomarkers on Cognitive Function in Adults at Risk of Cognitive Deterioration

Autor: David Ames, Michelle Lai, Ralph N. Martins, Nicola T. Lautenschlager, Graham Hepworth, Patricia Desmond, Elizabeth V. Cyarto, Kathryn A. Ellis, Matthew J. Sharman, Kay L. Cox, Colin L. Masters
Rok vydání: 2020
Předmět:
Male
0301 basic medicine
Oncology
medicine.medical_specialty
Trail Making Test
Population
Executive Function
03 medical and health sciences
Cognition
0302 clinical medicine
Memory
Risk Factors
Internal medicine
medicine
Humans
Cognitive Dysfunction
Effects of sleep deprivation on cognitive performance
education
Aged
Aged
80 and over

Inflammation
education.field_of_study
Mini–Mental State Examination
Framingham Risk Score
medicine.diagnostic_test
business.industry
Microcirculation
General Neuroscience
Australia
General Medicine
Neuropsychological test
Middle Aged
Mental Status and Dementia Tests
medicine.disease
Psychiatry and Mental health
Clinical Psychology
Cross-Sectional Studies
030104 developmental biology
Heart Disease Risk Factors
Female
Inflammation Mediators
Geriatrics and Gerontology
Alzheimer's disease
business
Biomarkers
Psychomotor Performance
030217 neurology & neurosurgery
Zdroj: Journal of Alzheimer's Disease. 74:163-171
ISSN: 1875-8908
1387-2877
DOI: 10.3233/jad-190953
Popis: Background: There is a paucity of information on the role of microvascular and inflammatory biomarkers in cognitive dysfunction. Objective: This study sought to evaluate the relationships between established and a number of peripheral biomarkers on cognitive patterns in 108 older adults with memory complaints. Methods: Participants in the AIBL Active study aged 60 years and older with at least one vascular risk factor and memory complaints completed a neuropsychological test battery and provided cross-sectional health data. Linear regression models adjusted for covariates examined associations between cognitive performance and a panel of vascular risk factors (Framingham cardiovascular scores, hs-CRP, homocysteine, fasting glucose, LDL-cholesterol) and peripheral biomarkers (TNF-α, BDNF, VCAM-1, ICAM-1, PAI-1, CD40L). Results: Higher fasting glucose and homocysteine levels were independent factors associated with poorer performance in Trail Making Test (TMT) B (adjusted β= 0.40±0.10 and 0.43±0.09, respectively). Increasing homocysteine levels were weakly associated with poorer global cognition and delayed recall (adjusted β= 0.23±0.10 and -0.20±0.10 respectively). Increasing Framingham cardiovascular scores were related to poorer performance in TMT B (β = 0.42±0.19). There was early evidence of associations between increasing plasma TNF-α and poorer TMT B (adjusted β = 0.21±0.10) and between increasing BDNF and better global cognition (β= -0.20±0.09). Conclusion: This study provides evidence to support the associations between vascular risk factors (Framingham scores, fasting glucose, and homocysteine) and poorer cognitive functions. Additionally, we measured several peripheral biomarkers to further investigate their associations with cognition. The relationship between TNF-α, BDNF, and cognitive performance in various domains may offer new insights into potential mechanisms in vascular cognitive impairment.
Databáze: OpenAIRE